(Q40272378)

19 September 2017

title

Serial procalcitonin levels to detect bacteremia in febrile neutropenia (English)

1 reference

19 September 2017

Aaron J Reitman

1

1 reference

19 September 2017

Rhonda M Pisk

series ordinal

2

1 reference

19 September 2017

John V Gates

series ordinal

3

1 reference

19 September 2017

J Daniel Ozeran

series ordinal

4

1 reference

19 September 2017

publication date

3 October 2012

1 reference

19 September 2017

1 reference

19 September 2017

volume

51

1 reference

19 September 2017

issue

12

1 reference

19 September 2017

page(s)

1175-1183

1 reference

Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Can

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Identification of children presenting with fever in chemotherapy‐induced neutropenia at low risk for severe bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Predicting bacteremia in children with fever and chemotherapy-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Risk prediction in pediatric cancer patients with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Infection risk factors in febrile, neutropenic children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Outpatient treatment of cancer patients with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

"Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Fever and neutropenia in pediatric patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Management of fever in patients with cancer and treatment-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Guidelines on blood cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Effect of number of blood cultures and volume of blood on detection of bacteremia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Current blood culture methods and systems: clinical concepts, technology, and interpretation of results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Kinetics of procalcitonin in iatrogenic sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Biomarkers in the critically ill patient: procalcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

The role of procalcitonin in febrile neutropenic patients: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Diagnostic and Prognostic Role of Procalcitonin in Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Effects of volume and site of blood draw on blood culture results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

Predicting the risk of bacteremia in childen with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922812460913

21 January 2018

Identifiers

DOI

10.1177/0009922812460913

1 reference

19 September 2017

1 reference